Article

7 Nov 2025

Garfield Weston Foundation Continues To Support Cure Leukaemia

Garfield Weston Foundation Continues To Support Cure Leukaemia

We are delighted to announce we have received the second payment of £150,000 as part of a two-year £300,000 commitment from the Garfield Weston Foundation, a partnership that we greatly value. This multi-year funding provides vital funding, allowing clinicians and blood cancer centres to plan ahead, knowing they have the resources to continue delivering and expanding life-saving blood cancer research.

Over the course of the two-year commitment, this £300,000 funding has supported three dedicated Cure Leukaemia Research Nurses, who are delivering life-saving clinical trials to patients across the UK.

Their work not only impacts the lives of patients today in the UK, also contributes to global research efforts, helping drive advances in blood cancer treatment worldwide.

The Garfield Weston Foundation is one of the UK’s largest grant-making foundations, supporting a broad range of charitable causes. We are deeply grateful for their continued support, which enables us to push forward with pioneering research and improve outcomes for patients across the country.

Want to continue to help support blood cancer patients?

Find More News

Cure Leukaemia Announced as Sir Chris Hoy’s Tour de 4  Charity Partner

Cure Leukaemia Announced as Sir Chris Hoy’s Tour de 4 Charity Partner

Six-time Olympic champion Sir Chris Hoy has today announced Cure Leukaemia as an official charity partner for the highly anticipated Tour de…
Close To A Cure with Sir Jason Kenny and Dame Laura Kenny

Close To A Cure with Sir Jason Kenny and Dame Laura Kenny

Close To A Cure with Sir Jason Kenny and Dame Laura Kenny On Tuesday, 15th September 2026, Cure…
“We Know Trials Save Children”

“We Know Trials Save Children”

Jo Hawkridge – We Know Trials Save Children In the latest episode of Cure Leukaemia’s Let’s Talk Blood…
ATICUS Network Reaches Major Milestone with Appointment of National Project Lead

ATICUS Network Reaches Major Milestone with Appointment of National Project Lead

The quest to revolutionise treatment for children battling blood cancer has taken a significant leap forward today as…
AMMO Trial Phase 2 Clinical Trial presented at ASH Conference

AMMO Trial Phase 2 Clinical Trial presented at ASH Conference

For nearly three decades, progress in treating a rare blood cancer called Chronic Myelomonocytic Leukaemia (CMML) had largely…
“I Decide When I Go, Not the Disease”

“I Decide When I Go, Not the Disease”

Adam Claxton’s Journey from a 100-Day Cough to Overcoming a Terminal Prognosis In the latest episode of Cure…
Davisons Law raises £24,000 for Cure Leukaemia

Davisons Law raises £24,000 for Cure Leukaemia

Davisons Law have smashed their Charity Fundraising Target by raising £24,000 for national blood cancer charity Cure Leukaemia…
Flutter becomes Cure Leukaemia’s first global partner with expanded three-year commitment

Flutter becomes Cure Leukaemia’s first global partner with expanded three-year commitment

As part of Flutter’s Do More ambition, this new $4 million (£3 million) partnership will fund specialist blood cancer nurses and help expand the Trials Acceleration Program  Flutter Entertainment…
Cure Leukaemia Launches ‘Let’s Talk Blood Cancer: The Patients’ Podcast

Cure Leukaemia Launches ‘Let’s Talk Blood Cancer: The Patients’ Podcast

We’re proud to announce the launch of Let’s Talk Blood Cancer: The Patients’ Podcast, a new series designed…